Aurobindo Pharma Inaugurates TheraNym, biologics contract manufacturing facility in Telangana
Business 03 Jun, 2026

Aurobindo Pharma Inaugurates TheraNym, biologics contract manufacturing facility in Telangana

Business To Business, Hyderabad, 3rd June, 2026:   The Aurobindo Pharma on Wednesday announced the inauguration of TheraNym, described as one of India’s largest dedicated biologics contract manufacturing organisations (CMO), located near Hyderabad.
Key highlights of the launch

  • TheraNym is positioned as a major biologics manufacturing facility focused on contract development and production for global pharmaceutical companies.
  • The project is part of Aurobindo Pharma’s expansion into the high-value biologics segment.
Government and industry presence
Before the inauguration, senior leaders of Aurobindo Pharma and executives from MSD met Telangana Chief Minister Anumula Revanth Reddy to brief him on the project and acknowledge government support.
The facility was formally inaugurated by Telangana ministers:
  • D. Sridhar Babu
  • Damodar Raja Narasimha
Significance
The launch of TheraNym reinforces Telangana’s positioning as a major hub for pharmaceuticals and biotechnology in India. The state government has been actively promoting investments in life sciences, aiming to attract global companies and strengthen infrastructure for advanced drug manufacturing.
For Aurobindo Pharma, the facility marks a strategic step into biologics manufacturing, a rapidly growing segment of the global pharmaceutical industry focused on complex, high-value therapies.
The collaboration with international partners such as MSD highlights increasing integration of Indian pharma capabilities into global biologics supply chains.

Related News